Skip to main content
Erschienen in: European Radiology 5/2006

01.05.2006 | Musculoskeletal

Whole-body MRI in the detection of bone marrow infiltration in patients with plasma cell neoplasms in comparison to the radiological skeletal survey

verfasst von: Nadir Ghanem, Christian Lohrmann, Monika Engelhardt, Gregor Pache, Markus Uhl, Ulrich Saueressig, Elmar Kotter, Mathias Langer

Erschienen in: European Radiology | Ausgabe 5/2006

Einloggen, um Zugang zu erhalten

Abstract

To compare the diagnostic value of whole-body MRI versus radiological skeletal survey (RSS) in staging patients with plasma cell neoplasms (PCN) and to evaluate the possible therapeutic impact of the replacement of RSS by whole-body MRI. Fifty-four patients with PCN [multiple myeloma (MM), n=47; monoclonal gammopathy of unknown significance (MGUS), n=7] were studied by whole-body MRI and RSS in a monocenter prospective analysis from August 2002 to May 2004. The MRIs were performed using a rolling table platform “AngioSURF” for unlimited field of view with a 1.5-T system (Magnetom Sonata/Maestro Class, Siemens Medical Solutions, Erlangen, Germany). A coronal STIR sequence (TR5500-4230/TE102-94/TI160) was used for imaging of the different body regions, including the head, neck, thorax, abdomen, pelvis and upper and lower extremities. The RSS consisted of eight different projections of the axial and appendicular skeleton. In 41/54 (74%) patients, the results of the whole-body MRI and RSS were concordant. In 11/54 (20%) patients, both imaging techniques were negative. Bone involvement was observed in 30/54 (55%) patients; however, whole-body MRI revealed this more extensively than the RSS in 27/30 (90%) patients with concordant positive imaging findings. In 3/30 (10%) patients, both imaging techniques demonstrated a similar extent of bone marrow infiltration. In 10/54 (19%) patients, the whole-body MRI was superior to RSS in detecting bone marrow infiltration, whereas the RSS was negative. In 3/54 (6%) patients, the RSS was proven to be false positive by the clinical course, whereas the whole-body MRI was truly negative. Whole-body MRI is a fast and highly effective method for staging PCN patients by the use of a rolling table platform. Moreover, it is more sensitive and specific than RSS and reveals bone marrow infiltration and extensive disease more reliably. Therefore, whole-body MRI should be performed as an additional method of exactly staging PCN patients and - with more data in the field - may even prove to be an alternate and more sensitive staging procedure than RSS in PCN patients.
Literatur
1.
Zurück zum Zitat Munshi NC, Tricot G, Barlogie B. Plasma cell neoplasms. In: De Vita VT, Hellmann S, Rosenberg SA (eds) Cancer: principles and pratice of oncology, Lippincott, Philadelphia Munshi NC, Tricot G, Barlogie B. Plasma cell neoplasms. In: De Vita VT, Hellmann S, Rosenberg SA (eds) Cancer: principles and pratice of oncology, Lippincott, Philadelphia
2.
Zurück zum Zitat Durie BGM, Salmon S (1975) A clinical staging system for multiple myeloma. Cancer 36:842–854PubMedCrossRef Durie BGM, Salmon S (1975) A clinical staging system for multiple myeloma. Cancer 36:842–854PubMedCrossRef
3.
Zurück zum Zitat Malpas JS, Caroll JJ (1995) Myeloma: clinical presentation and diagnosis. In: Malpass JS, Bergsagel DE, Kyle RA (eds) Myeloma: biology and management, Oxford Univeristy Press, New York, NY, p 169 Malpas JS, Caroll JJ (1995) Myeloma: clinical presentation and diagnosis. In: Malpass JS, Bergsagel DE, Kyle RA (eds) Myeloma: biology and management, Oxford Univeristy Press, New York, NY, p 169
4.
Zurück zum Zitat Alexanian R, Dimopoulos MA (1995) Management of multiple myeloma. Semin Hematol 32:20–30PubMed Alexanian R, Dimopoulos MA (1995) Management of multiple myeloma. Semin Hematol 32:20–30PubMed
6.
Zurück zum Zitat Swanson D (2001). Guideline: diagnosis and management of multiple myeloma. Br J Hematol 115:522–540CrossRef Swanson D (2001). Guideline: diagnosis and management of multiple myeloma. Br J Hematol 115:522–540CrossRef
7.
Zurück zum Zitat Barlogie B, Shaughnessy J, Tricot G et al (2004) Treatment of multiple myeloma. Blood 103:20–32CrossRefPubMed Barlogie B, Shaughnessy J, Tricot G et al (2004) Treatment of multiple myeloma. Blood 103:20–32CrossRefPubMed
8.
Zurück zum Zitat Daffner RH, Lupetin AR, Dash N, Deeb ZL, Sefczek RJ, Schapiro RL (1986) MRI in the detection of bone marrow. AJR Am J Roentgenol 146:353–358PubMed Daffner RH, Lupetin AR, Dash N, Deeb ZL, Sefczek RJ, Schapiro RL (1986) MRI in the detection of bone marrow. AJR Am J Roentgenol 146:353–358PubMed
9.
Zurück zum Zitat Fruehwald F, Tscholakoff D, Schwaighofer B, Wicke L, Neuhold A, Ludwig H, Hajek PC (1988) MRI of the lower vertebral column in patients with multiple myeloma. Invest Radiol 23:193–199PubMedCrossRef Fruehwald F, Tscholakoff D, Schwaighofer B, Wicke L, Neuhold A, Ludwig H, Hajek PC (1988) MRI of the lower vertebral column in patients with multiple myeloma. Invest Radiol 23:193–199PubMedCrossRef
10.
Zurück zum Zitat Tertti R, Alanen A, Rhemes K (1995) The value of magnetic resonance imaging in screening myeloma lesions of the lumbar spine. Br J Haematol 91:658–660PubMed Tertti R, Alanen A, Rhemes K (1995) The value of magnetic resonance imaging in screening myeloma lesions of the lumbar spine. Br J Haematol 91:658–660PubMed
11.
Zurück zum Zitat Altehoefer C, Ghanem N, Högerle S, Moser E, Langer M (2001) Comparative detectability of bone metastases and impact on therapy of magnetic resonance imaging and bone scintigraphy in patients with breast cancer. Eur J Radiol 40:16–23CrossRefPubMed Altehoefer C, Ghanem N, Högerle S, Moser E, Langer M (2001) Comparative detectability of bone metastases and impact on therapy of magnetic resonance imaging and bone scintigraphy in patients with breast cancer. Eur J Radiol 40:16–23CrossRefPubMed
12.
Zurück zum Zitat Ghanem N, Altehoefer C, Högerle S, Schäfer O, Winterer J, Moser E, Langer M (2002) Comparative diagnostic value and therapeutic relevance of magnetic resonance imaging and bone marrow scintigraphy in patients with metastastic solid tumors of the axial skeleton. Eur J Radiol 43:256–261CrossRefPubMed Ghanem N, Altehoefer C, Högerle S, Schäfer O, Winterer J, Moser E, Langer M (2002) Comparative diagnostic value and therapeutic relevance of magnetic resonance imaging and bone marrow scintigraphy in patients with metastastic solid tumors of the axial skeleton. Eur J Radiol 43:256–261CrossRefPubMed
13.
Zurück zum Zitat Moulopoulus LA, Dimopoulus MA (1997). Magnetic resonance imaging of the bone marrow in hematologic malignancies. Blood 90:2127–2147PubMed Moulopoulus LA, Dimopoulus MA (1997). Magnetic resonance imaging of the bone marrow in hematologic malignancies. Blood 90:2127–2147PubMed
14.
Zurück zum Zitat Altehoefer C, Blum U, Bathmann J et al (1997) Comparative accuracy of magnetic resonance imaging and immunoscintigraphy for detection of bone marrow involvement in patients with malignant lymphoma. J Clin Oncol 15:1754–1760PubMed Altehoefer C, Blum U, Bathmann J et al (1997) Comparative accuracy of magnetic resonance imaging and immunoscintigraphy for detection of bone marrow involvement in patients with malignant lymphoma. J Clin Oncol 15:1754–1760PubMed
15.
Zurück zum Zitat Rahmouni A, Divine M, Mathieu D et al (1993) Detection of multiple myeloma involving the spine: Efficacy of fat suppression and contrast-enhanced MR imaging. AJR Am J Roentgenol 160:1049–1052PubMed Rahmouni A, Divine M, Mathieu D et al (1993) Detection of multiple myeloma involving the spine: Efficacy of fat suppression and contrast-enhanced MR imaging. AJR Am J Roentgenol 160:1049–1052PubMed
16.
Zurück zum Zitat Vande Berg BC, Malghem J, Lecouvet FE, Maldague B (1998) Classification and detection of bone marrow lesions with magnetic resonance imaging. Skeletal Radiol 27:529–545CrossRefPubMed Vande Berg BC, Malghem J, Lecouvet FE, Maldague B (1998) Classification and detection of bone marrow lesions with magnetic resonance imaging. Skeletal Radiol 27:529–545CrossRefPubMed
17.
Zurück zum Zitat Dimopoulus MA, Moulopoulus LA, Datseris I, Weber D, Delasalle K, Gika D, Alexanian R (2000) Imaging of myeloma bone disease-implications for staging, prognosis and follow-up. Acta Oncol 39:823–827CrossRefPubMed Dimopoulus MA, Moulopoulus LA, Datseris I, Weber D, Delasalle K, Gika D, Alexanian R (2000) Imaging of myeloma bone disease-implications for staging, prognosis and follow-up. Acta Oncol 39:823–827CrossRefPubMed
18.
Zurück zum Zitat Vande Berg BC, Michaux L, Lecouvet FE et al (1997) Nonmyelomatous monoclonal gammopathy: correlation of bone marrow MR images with laboratory findings and spontaneous clinical outcome. Radiology 202:247–251PubMed Vande Berg BC, Michaux L, Lecouvet FE et al (1997) Nonmyelomatous monoclonal gammopathy: correlation of bone marrow MR images with laboratory findings and spontaneous clinical outcome. Radiology 202:247–251PubMed
19.
Zurück zum Zitat Baur A, Stäbler A, Nagel D et al (2002) Magnetic resonance imaging as a supplement for clinical staging system of Durie and Salmon? Cancer 95:1334–1345CrossRefPubMed Baur A, Stäbler A, Nagel D et al (2002) Magnetic resonance imaging as a supplement for clinical staging system of Durie and Salmon? Cancer 95:1334–1345CrossRefPubMed
20.
Zurück zum Zitat Stäbler A, Baur A, Bartl R, Munker R, Lamerz R, Reiser MF (1996) Contrast enhancement and quantitative signal analysis in MR imaging of multiple myeloma: assessment of focal and diffuse growth patterns in marrow correlated with biopsies and survival rates. AJR Am J Roentgenol 167: 1029–1036PubMed Stäbler A, Baur A, Bartl R, Munker R, Lamerz R, Reiser MF (1996) Contrast enhancement and quantitative signal analysis in MR imaging of multiple myeloma: assessment of focal and diffuse growth patterns in marrow correlated with biopsies and survival rates. AJR Am J Roentgenol 167: 1029–1036PubMed
21.
Zurück zum Zitat Lecouvet FE, Malghem J, Michaux L et al (1999) Skeletal survey in advanced multiple myeloma: radiographic versus MR imaging survey. Br J Haematol 106:35–39CrossRefPubMed Lecouvet FE, Malghem J, Michaux L et al (1999) Skeletal survey in advanced multiple myeloma: radiographic versus MR imaging survey. Br J Haematol 106:35–39CrossRefPubMed
22.
Zurück zum Zitat Walker RE, Eustace SJ (2001) Whole body magnetic resonance imaging: techniques, clinical indications, and future applications. Semin Musculoskel Radiol 5:5–20CrossRef Walker RE, Eustace SJ (2001) Whole body magnetic resonance imaging: techniques, clinical indications, and future applications. Semin Musculoskel Radiol 5:5–20CrossRef
23.
Zurück zum Zitat Schick F (2005) Whole-body MRI at high field: technical limits and clinical potential. Eur Radiol 15:946–959CrossRefPubMed Schick F (2005) Whole-body MRI at high field: technical limits and clinical potential. Eur Radiol 15:946–959CrossRefPubMed
24.
Zurück zum Zitat Eustace S, Tello R, DeCarvalho V, Carey J, Melhem E, Yucel EK (1997). A comparison of whole-body turboSTIR MR imaging and planar 99m Tc-methylene diphosphonate scintigraphy in the examination of patients with suspected skeletal metastases. AJR Am J Roentgenol 169:1665 Eustace S, Tello R, DeCarvalho V, Carey J, Melhem E, Yucel EK (1997). A comparison of whole-body turboSTIR MR imaging and planar 99m Tc-methylene diphosphonate scintigraphy in the examination of patients with suspected skeletal metastases. AJR Am J Roentgenol 169:1665
25.
Zurück zum Zitat Steinborn MM, Heuck AF, Tiling R, Bruegel M, Gauger L, Reiser MF (1999) Whole-body bone marrow MRI in patients with metastastic disease to skeletal system. J Comput Assit Tomogr 23:123–129CrossRef Steinborn MM, Heuck AF, Tiling R, Bruegel M, Gauger L, Reiser MF (1999) Whole-body bone marrow MRI in patients with metastastic disease to skeletal system. J Comput Assit Tomogr 23:123–129CrossRef
26.
Zurück zum Zitat Ghanem N, Kelly T, Altehoefer C, et al (2004) Whole-body MRI in comparison to skeletal scintigraphy for detection of skeletal metastases in patients with solid tumors. Radiologe 44:864–874CrossRefPubMed Ghanem N, Kelly T, Altehoefer C, et al (2004) Whole-body MRI in comparison to skeletal scintigraphy for detection of skeletal metastases in patients with solid tumors. Radiologe 44:864–874CrossRefPubMed
27.
Zurück zum Zitat Ghanem N, Altehoefer C, Winterer J, Högerle S, Ghanem-Wiesel C, Langer M (2002) Whole body MRI in staging cancer patients: A comparison with whole-body FDG-PET. Cancer Imaging 3:18–19 Ghanem N, Altehoefer C, Winterer J, Högerle S, Ghanem-Wiesel C, Langer M (2002) Whole body MRI in staging cancer patients: A comparison with whole-body FDG-PET. Cancer Imaging 3:18–19
28.
Zurück zum Zitat Daldrup-Link HE, Franzius C, Link TM, Laukamp D, Sciuk J, Jürgens H, Schober O, Rummeny EJ (2001) Whole-body MR imaging for detection of bone metastases in children and young adults: Comparison with skeletal scintigraphy and FDG-PET. AJR Am J Roentgenol 177: 229–236PubMed Daldrup-Link HE, Franzius C, Link TM, Laukamp D, Sciuk J, Jürgens H, Schober O, Rummeny EJ (2001) Whole-body MR imaging for detection of bone metastases in children and young adults: Comparison with skeletal scintigraphy and FDG-PET. AJR Am J Roentgenol 177: 229–236PubMed
29.
Zurück zum Zitat Lauenstein TC, Freudenberg LS, Goehde SC, Ruehm SG, Goyen M, Bosk S, Debatin JF, Barkhausen J (2002) Whole-body MRI using a rolling for detection of bone metastases. Eur Radiol 12:2091–2099PubMed Lauenstein TC, Freudenberg LS, Goehde SC, Ruehm SG, Goyen M, Bosk S, Debatin JF, Barkhausen J (2002) Whole-body MRI using a rolling for detection of bone metastases. Eur Radiol 12:2091–2099PubMed
30.
Zurück zum Zitat Steinborn MM, Heuck AF, Tiling R, Bruegel M, Gauger L, Reiser MF (1999) Whole-body bone marrow MRI in patients with metastastic disease to skeletal system. J Comput Assit Tomogr 23:123–129CrossRef Steinborn MM, Heuck AF, Tiling R, Bruegel M, Gauger L, Reiser MF (1999) Whole-body bone marrow MRI in patients with metastastic disease to skeletal system. J Comput Assit Tomogr 23:123–129CrossRef
31.
Zurück zum Zitat Mentzel HJ, Kentouche K, Sauner D et al (2004) Comparison of whole-body STIR-MRI and 99mTc-methylene-diphosphonate scintigraphy in children with suspected multifocal bone lesions. Eur Radiol 14: 2297–2302CrossRefPubMed Mentzel HJ, Kentouche K, Sauner D et al (2004) Comparison of whole-body STIR-MRI and 99mTc-methylene-diphosphonate scintigraphy in children with suspected multifocal bone lesions. Eur Radiol 14: 2297–2302CrossRefPubMed
32.
Zurück zum Zitat Kellenberger CJ, Miller SF, Khan M, Gilday DL, Weitzman S, Babyn PS (2004) Initial experience with FSE STIR whole-body MR imaging for staging lymphoma in children. Eur Radiol 14:1829–1841CrossRefPubMed Kellenberger CJ, Miller SF, Khan M, Gilday DL, Weitzman S, Babyn PS (2004) Initial experience with FSE STIR whole-body MR imaging for staging lymphoma in children. Eur Radiol 14:1829–1841CrossRefPubMed
33.
Zurück zum Zitat Lizuka-Mikami M, Nagai K, Yoshida K et al (2004) Detection of bone marrow and extramedullary involvement in patients with non-Hodgkin’s lymphoma by whole-body MRI: comparison with bone and 67 Ga scintigraphies. Eur Radiol 14:1074–1081PubMedCrossRef Lizuka-Mikami M, Nagai K, Yoshida K et al (2004) Detection of bone marrow and extramedullary involvement in patients with non-Hodgkin’s lymphoma by whole-body MRI: comparison with bone and 67 Ga scintigraphies. Eur Radiol 14:1074–1081PubMedCrossRef
34.
Zurück zum Zitat Schlemmer HP, Schäfer J, Pfannenberg C et al (2005) Fast whole-body assessment of metastatic disease using a novel magnetic resonance imaging system. Initial experiences. Invest Radiol 40:64–71CrossRefPubMed Schlemmer HP, Schäfer J, Pfannenberg C et al (2005) Fast whole-body assessment of metastatic disease using a novel magnetic resonance imaging system. Initial experiences. Invest Radiol 40:64–71CrossRefPubMed
Metadaten
Titel
Whole-body MRI in the detection of bone marrow infiltration in patients with plasma cell neoplasms in comparison to the radiological skeletal survey
verfasst von
Nadir Ghanem
Christian Lohrmann
Monika Engelhardt
Gregor Pache
Markus Uhl
Ulrich Saueressig
Elmar Kotter
Mathias Langer
Publikationsdatum
01.05.2006
Verlag
Springer-Verlag
Erschienen in
European Radiology / Ausgabe 5/2006
Print ISSN: 0938-7994
Elektronische ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-005-0055-7

Weitere Artikel der Ausgabe 5/2006

European Radiology 5/2006 Zur Ausgabe

PET kann infarktgefährdete Koronararterien entdecken

04.06.2024 Koronare Herzerkrankung Nachrichten

Der Nachweis aktiver Plaques mittels 18F-Natriumfluorid-PET hilft nicht nur, infarktgefährdete Patienten, sondern auch infarktgefährdete Koronararterien zu erkennen. Von einer gezielten Behandlung vulnerabler Plaques ist man trotzdem weit entfernt.

Mammakarzinom: Brustdichte beeinflusst rezidivfreies Überleben

26.05.2024 Mammakarzinom Nachrichten

Frauen, die zum Zeitpunkt der Brustkrebsdiagnose eine hohe mammografische Brustdichte aufweisen, haben ein erhöhtes Risiko für ein baldiges Rezidiv, legen neue Daten nahe.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Klinikreform soll zehntausende Menschenleben retten

15.05.2024 Klinik aktuell Nachrichten

Gesundheitsminister Lauterbach hat die vom Bundeskabinett beschlossene Klinikreform verteidigt. Kritik an den Plänen kommt vom Marburger Bund. Und in den Ländern wird über den Gang zum Vermittlungsausschuss spekuliert.

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.